Collagenase or fasciotomy for the treatment of Dupuytren’s contracture? A network meta- analysis. .
OrthoEvidence Journal (OE Journal) - OE Original
OE Journal. 2019;7(13):1Evidence comparing collagenase and fasciotomy for Dupuytren’s contracture suggests both treatments offer meaningful short-term and sustained improvement, with clear advantages over placebo in reducing contracture and increasing motion. No meaningful difference emerges when the two treatments are compared directly. Safety signals, however, differ: collagenase shows a notable rise in adverse events relative to placebo, while fasciotomy does not, though available data for fasciotomy are limited. Overall, findings point to comparable efficacy but raise caution around collagenase safety, highlighting the need for larger, methodologically robust trials to refine confidence in both benefit and risk.
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!